Gene Therapy With Modified Autologous Hematopoietic Stem Cells for the Treatment of Patients With Mucopolysaccharidosis Type I, Hurler Variant
Clinical trial NCT03488394 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03488394
- Sponsor
- Orchard Therapeutics
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-05-11
- Primary completion
- 2035-01-01
- Enrollment
- 8
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.